deltatrials
Completed PHASE1 INTERVENTIONAL 5-arm NCT00199875

Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250

Cohort Study of Increasing Doses of Yttrium-90 Conjugated to Chimeric Monoclonal Antibody cG250 (^90Y-DOTA-cG250) in Patients With Advanced Renal Cancer

Sponsor: Ludwig Institute for Cancer Research

Conditions Kidney Cancer Kidney Neoplasm Renal Cancer Renal Cell Carcinoma
Interventions Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
Updated 8 times since 2017 Last updated: Oct 3, 2022 Started: Jul 6, 2005 Primary completion: Mar 14, 2013 Completion: Mar 14, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Kidney Cancer and Kidney Neoplasm and is currently completed. Ludwig Institute for Cancer Research leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotUnknown Status~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshotUnknown Status~Dec 2018 – ~Jan 2021 · 25 months · monthly snapshotCompleted~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotCompleted~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jan 2021 — Nov 2022 [monthly]

    Completed PHASE1

  5. Dec 2018 — Jan 2021 [monthly]

    Completed PHASE1

    Status: Unknown Status → Completed

▶ Show 3 earlier versions

  1. Jun 2018 — Dec 2018 [monthly]

    Unknown Status PHASE1

  2. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE1

  3. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE1

    First recorded

Jul 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ludwig Institute for Cancer Research
  • Memorial Sloan Kettering Cancer Center
Data source: Ludwig Institute for Cancer Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations